Characterizing the Patient Journey in Multiple Myeloma: Qualitative Review

Journals

1. Midha S, Hartley-Brown M, Mo C, Hossain S, Nadeem O, O’Donnell E, Bianchi G, Sperling A, Laubach J, Richardson P. A safety review of recently approved and emerging drugs for patients with relapsed or refractory multiple myeloma. Expert Opinion on Drug Safety 2023;22(11):1049 View
2. Hansen D, Bixby T, Fixler K, Shea L, Brittle C, Brunisholz K, Liu Y, Huo J. Experience of Autologous Stem Cell Transplant in Multiple Myeloma: The Patient and Caregiver Perspective. Journal of Patient Experience 2023;10 View
3. Peña C, Graffigna P, Russo M, Forray E, Bustamante P. Improved overall survival of transplant eligible newly diagnosed multiple myeloma patients in a Chilean public center. How did we achieve it?. Hematology, Transfusion and Cell Therapy 2024;46(4):575 View
4. Cerejo C. The untold emotional toll of navigating the health system: the journey of patients in/from India, living with serious and/or chronic conditions. Current Medical Research and Opinion 2024;40(9):1605 View
5. Dwyer Orr L, Lin D, Wu B, LeBlanc T, Faiman B, Ahlstrom J, Yung M, Deering K, Kulbokas V, Feldman J, Kline E, Biran N. Patient, Care Partner, and Physician Voices in Treatment Decision-Making for Multiple Myeloma. Patient Preference and Adherence 2024;Volume 18:2147 View
6. Liu Q, Li J, Wang L, Shan C, Wang L, Ye D, Luo D, Zou H, Yang B, Wang X, Zhang J, Zhou F. Shared decision‐making about autologous stem cell transplantation: A qualitative study of older patients and physicians. Journal of the American Geriatrics Society 2025;73(2):458 View
7. Kylies J, Dirks M, Brauneck E, Tessarzyk M, Dreimann M, Strahl A, Wolters W, Weisel K, Leonhardt L, Viezens L. Changes in sagittal spinopelvic alignment are associated with increased pain and impaired function in multiple myeloma patients. European Spine Journal 2025;34(8):3513 View
8. Park Y, Kim S, Kim N, Park J, Bang G, Kang D, Yoon S, Kim K, Cho J, Kim S. Different Level and Difficulties with Financial Burden in Multiple Myeloma Patients and Caregivers: A Dyadic Qualitative Study. Seminars in Oncology Nursing 2025;41(4):151848 View
9. Nottingham K, Crawford R, Starkie S, Shaffer L. Challenges of COVID: Lessons Learned From Living Kidney Donors’ Experience. Journal of Patient Experience 2025;12 View
10. Matthews E, Montague-Hellen K, Bird J. Finding the Right Time to Discuss Advance Care Planning with Myeloma Patients and Their Carers: An Opportunity for Nursing. Seminars in Oncology Nursing 2025;41(5):151913 View
11. Zhu L, Nawaz M, Zuo Y, Zeng P. Next-generation immunotherapy in relapsed/refractory multiple myeloma: Strategies to achieve sustained MRD negativity. Critical Reviews in Oncology/Hematology 2025;214:104913 View
12. Kuo Y, Hung Y, Peng H, Huang B, Chen S. Symptom distress and fear of progression associated with quality of life in multiple myeloma patients receiving treatment. Supportive Care in Cancer 2025;33(12) View
13. Lee H, Zonder J, Dhodapkar M, Jagannath S, Hoffman J, Suvannasankha A, Shah M, Lentzsch S, Baz R, Maly J, Namburi S, Pianko M, Ye J, Wu K, Silbermann R, Min C, Vekemans M, Munder M, Byun J, Martínez-Lopez J, DeVeaux M, Roccia T, Chokshi D, Seraphin M, Knorr K, Boyapati A, Hazra A, Lorenc K, Kroog G, Bumma N, Richter J. Linvoseltamab in Patients with Relapsed/Refractory Multiple Myeloma in the LINKER-MM1 Study: Longer Follow-Up and Subgroup Analyses. Clinical Lymphoma Myeloma and Leukemia 2025 View